22 October 2020 Arena Point Merrion Way REF: SHA/23378 Leeds LS2 8PA APPEAL AGAINST NHS COMMISSIONING BOARD Tel: 0203 928 2000 ("NHS ENGLAND") DECISION TO REFUSE AN Fax: 0207 821 0029 APPLICATION BY RUSHPORT ADVISORY LLP FOR Email:
[email protected] INCLUSION IN THE PHARMACEUTICAL LIST OFFERING UNFORESEEN BENEFITS UNDER REGULATION 18 AT THE NEW HEALTH CENTRE, KENT & CANTERBURY HOSPITAL, ETHELBERT ROAD, CANTERBURY, KENT, CT1 3NG 1 Outcome 1.1 The Pharmacy Appeals Committee (“Committee”), appointed by NHS Resolution, quashes the decision of NHS England and redetermines the application. 1.2 The Committee determined that the application should be refused. NHS Resolution is the operating name of NHS Litigation Authority – we were established in 1995 as a Special Health Authority and are a not-for-profit part of the NHS. Our purpose is to provide expertise to the NHS on resolving concerns fairly, share learning for improvement and preserve resources for patient care. To find out how we use personal information, please read our privacy statement at https://resolution.nhs.uk/privacy-cookies/primary-care- appeals/ 22 October 2020 REF: SHA/23378 Arena Point Merrion Way APPEAL AGAINST NHS COMMISSIONING BOARD Leeds ("NHS ENGLAND") DECISION TO REFUSE AN LS2 8PA APPLICATION BY RUSHPORT ADVISORY LLP FOR Tel: 0203 928 2000 INCLUSION IN THE PHARMACEUTICAL LIST Fax: 0207 821 0029 OFFERING UNFORESEEN BENEFITS UNDER Email:
[email protected] REGULATION 18 AT THE NEW HEALTH CENTRE, KENT & CANTERBURY HOSPITAL, ETHELBERT ROAD, CANTERBURY, KENT, CT1 3NG 1 The Application By application dated 17 December 2019, Rushport Advisory LLP (“the Applicant”) applied to NHS Commissioning Board (“NHS England”) for inclusion in the pharmaceutical list offering unforeseen benefits under Regulation 18 at the New Health Centre, Kent & Canterbury Hospital, Ethelbert Road, Canterbury, Kent CT1 3NG.